Follow us on :


Take a look at the Recent articles

Clinical pathological analysis in 104 ductal breast cancer cases

Yueling Jin

Department of Pathology, Shanghai University of Medicine & Health Sciences, Shanghai, 201318, China

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Zhensheng Dai

Department of Hematology-Oncology, Shanghai Pudong Hospital Affiliated to Fudan University, Shanghai, 201399, China

DOI: 10.15761/CDP.1000118

Article
Article Info
Author Info
Figures & Data

Abstract

Ductal breast cancer is a clinically heterogeneous disease; we investigate the correlation between tumor size, comedo necrosis, number of cell mitoses and axillary lymph node metastasis in ductal breast cancer. In this study, 104 ductal breast cancer specimens were collected and divided into 3 groups T1 group (tumor size ≦ 2 cm), T2 group (2< tumor size≦5cm) and T3 group (tumor size>5.0cm). Among those specimens, 95 cases were diagnosed with invasive ducted carcinoma, 9 cases were ductal carcinoma in-situ (DCIS). Results shown that T3 group has a higher rate of axillary lymph node metastasis than T2 group and T1 group; T2 group has a higher rate of lymph node metastasis than T1 group. The patients with the number of cell mitoses(≧10)were also has a higher rate of axillary lymph node metastasis (P = 0.0139) than the patients with the number of cell mitoses (<10). No significance was found between comedo necrosis lesions and axillary lymph node metastasis, though the frequency of comedo necrosis lesions in patients with axillary lymph node metastasis was higher than those in non-metastatic patients. It is concluded that the tumor size and the number of cell mitoses were risk factors for axillary lymph node involvement in ductal breast cancer.

Key words

Pathological analysis; Ductal breast cancer; Lymph node metastasis

Introduction

Breast cancer is the most common malignant tumor among women, most of which are confirmed by patholoagical examination. In this study, 104 cases of ductal breast cancer specimens were collected. We analyzed and discussed the relationship between the tumor size, comedo necrosis, the number of cell mitoses and axillary lymph node metastasis.

Patients

Patient samples

Samples were retrieved from 104 ductal breast cancer patients, tissues were made into paraffin blocks and HE staining, diagnosed by pathological doctors. Pathological type: 9 cases of carcinoma in situ (Fig.1A), 95 cases of invasive ductal carcinoma (Fig.1B).

Figure 1.

Age distribution of patients

All cases were female. Age ranged from 24 to 83 years old. 2 cases of breast cancer patients under the age of 30, 10 cases of 31 to 40 years, 31 cases of 41 to 50 years, 20 cases of 51 to 60 years, 22 cases of 61 to 70 years, 19 cases of over 71 years old (Table 1); 56 tumors are in left breast, 47 cases in right, 1 case was bilateral.

Methods

Hematoxylin and Eosin staining

The original tumours have been fixed in 4% formaldehyde for 24 h, and then embedded in paraffin. Paraffin blocks were made of 3 ~ 4 μm thick sections, after routine hematoxylin and eosin staining; the pathologist observed the histopathological changes and classified the grade under optical microscope.

Classification of samples The largest diameter size of gross tumor as the measure standards, the samples were divided into three groups: T1 group (tumor size ≦ 2 cm), T2 group (2< tumor size≦5cm) and T3 group (tumor size>5.0cm). According to Bloom-Richardson histological grading system, we divided infiltrative breast cancer into I, II, and III grade.

Statistical analyses

Analysis was performed using GraphPad software, statistical analysis was performed by Fisher’s exact test, P<0.05 was considered to indicate a statisti­cally significant difference.

Results

Relationship between breast cancer tumor size and axillary lymph node metastasis

Grossly, T1 group 35 cases, T2 group 56 cases, and T3 group 13 cases. Results shown: T3 group has a higher rate of axillary lymph node metastasis (92.3%) than T2 group (51.8%) and T1 group (25. 7%); T2 group (51.8%) has a higher rate of lymph node metastasis than T1 group (25.7%). All the comparison between those two groups were statistical significant (P<0.05) (Table 1).

The relationship between comedo necrosis、lymph node metastasis and stage of breast cancer

In the 50 breast cancer cases who had lymph node metastasis, there were 39 cases accompanied comedo necrosis, while 21 cases with comedo necrosis among 53 cases with no lymph node metastasis. Although the rate of lymph node metastasis patients accompanied comedo necrosis (39/103) was higher than the rate of without lymph node metastatic rate (21/103), there was no significant difference (P > 0.05). Results also shown that, with the increase of tumor clinical grade, the number of samples with comedo necrosis also gradually increased, but there was no significant difference (Table 2).

The relationship between the number of cell mitoses and axillary lymph node metastasis

Results are shown in table 3. In the high-power fields (×400), we count the number of cell mitoses. 104 cases of resected specimens with invasive breast cancer were divided into two groups: 0 ~ 9 mitoses in high-power fields as a group I, ≧10 mitoses as a group II. We analyzed the difference between those two groups. The results shown that the number of patients with axillary lymph node metastasis in group II more than that of group I, the difference was statistically significant (P < 0.05).

Discussion

Ductal breast cancer is a clinically heterogeneous disease. About 10% to 15% of breast cancer patients have distant metastases within 2 years, which significantly reduced the 5-year survival rate [1]. Staging, Tumor size and lymph node metastasis are important prognostic factors for breast cancer metastasis, and in those factors, lymph node metastasis is the most important effect on ductal breast cancer prognosis.

We analyzed the pathological diagnoses on 104 cases of ductal breast cancer, the results showed (Figure 2), the peak of the age on breast cancer is still more than 40 years old. But it is worthy of mentioning that within 12 patients less than 40 years old, 7 (58.33%) had axillary lymph node metastases. The youngest was 24 years old, who was diagnosed as invasive ductal carcinoma, axillary lymph node metastasis is positive. Therefore, it is suggested that in any age group of women, as long as the breast tumor is found, it should be pay great attention to do a physical check, so to improve the early diagnosis rate, and do the best measures on improving the survival of breast cancer.

Figure 2. Age of breast cancer patients. 1: ≦30y,2; 31-40y; 3:41-50y, 4: 51-60y, 5; 61-70y, 6: ≧71y.

Table 1 shows the relationship between the breast cancer tumor size and axillary lymph node metastasis, the larger the tumor size the higher rate of axillary lymph node metastasis. Breast cancer axillary lymph node metastasis rate was 25.7% in T1 Group, 51.8% in T2 group, and in T3 group, the axillary lymph node metastasis rate rose to 92.3%. There were statistically significant differences between different groups compassion. Recently, study confirmed, monitoring the prognosis marker on breast cancer metastasis has positive correlation with the tumor size [2]. Such as, there is correction between high serum concentration (more than or equal to 2 mu / ml) ck19-2g2 and the tumor size (more than or equal to 2 cm). But in the early stage of breast cancer, tumors often cannot be checked out. So, research on relative tumor marker has a great value of diagnosing breast cancer.

Table 1. The relationship between tumor size and lymph node metastasis.

Tumor size

number of patient (cases)

lymph node (+) (cases/percentage)

lymph node (-) (cases/percentage)

T1

35

9(25.7%)

24(74.3%)

T2

56

29(51.8%)

28(48.2%)

T3

13

12(92.3%)

2(7.7%)

lymph node positive rate of group T2 compared with group T1, P = 0.0418, P<0.05;T3compared with T2, P = 0.0184, P<0.05;T3 compared with T1, P = 0.0003, P<0.05.

Reports have revealed comedo necrosis is a valuable predictive factor of breast tumor recurrence risk factors [3]. Comedo necrosis also could be seen in small breast infiltrating cancer such as ductal carcinoma in situ, which has high risk of axillary lymph node metastasis [4]. And the prognosis of comedo necrosis ductal carcinoma in situ was more poor than the non- comedo necrosis ductal carcinoma in situ [5-6]. Within the 104 cases of breast cancer tissues, we got 9 cases of patients with carcinoma in situ. Therefore, we analyze the relationship among the comedo necrosis, stage and axillary lymph node metastasis. Our results shown there was no statistically significant difference between comedo necrosis and lymph node metastasis (table 2), but there still was 39/103 of lymph node metastasis cases with comedo necrosis, the ratio was higher than no lymph node metastasis cases (21/103). Then we analyzed comedo necrosis combined with lymph node metastasis cases in different breast cancer stage. In stage I there were 13.3% cases had comedo necrosis combined with lymph node metastasis, while in stage II and III, the ratio was34.4% and 45.8% respectively (Table 3). Data revealed that perhaps higher tumor stage in ductal breast cancer has higher ratio of comedo necrosis lesions and lymph node metastasis, however, there is no significant difference between the statistical results, which is most likely due to the number of limited cases.

Table 2. The relationship between comedo necrosis, lymph node metastasis and stage of breast cancer.

grade

n

comedo necrosis/ lymph node (+)

comedo necrosis/ lymph node (-)

15

2(13.3%)

3(20.0%)

29

10(34.5%)

7(24.1%)

59

27(45.8%)

11(18.6%)

uncertain

1

 

 

n: number of cases. Group comedo necrosis/ lymph node (+) compared with group comedo necrosis/ lymph node (+), P>0.05).

Table 3. The relationship between the number of cell mitoses and axillary lymph nodes metastasis.

number of cell mitoses

n

lymph node (+)

lymph node (-)

0-9 

54

19(35.2%)

35(64.8%)

≧10  

50

31(62.0%)

19(38.0%)

n: number of cases. The number of patients with axillary lymph node metastasis in group II more than that of group I, the difference was statistically significant(P=0.0139;P<0.05).

Some scholars believe that cell mitoses represent the biological behavior of the tumor and can make greater value and clinical significance [7]. With the application of computer automatic image analysis technology in the detection of prognostic markers in breast cancer [8-12], the counting method of nuclear fission image now becomes more and more accurately. In this study, we watched the relationship between number of cell mitoses and axillary lymph node metastasis. Data shown that the group (≧10 cell mitoses) showed significantly higher patient with axillary lymph node metastasis compared to the group (0-9 cell mitoses) (P = 0.0100) (Table 4).

Every 100 thousand women in the United States from 25 to 39 years of age, the incidence of breast cancer increased from 1.53% in 2009 to 2.90% in 1976 [13]. In recent years, the incidence of female breast cancer in China is also rising, and the disease incidence showed younger trend. Lymph node metastasis may reflect the biologic behavior of the tumor, to analysis the pathological features of breast cancer, and to explore the related factors of axillary lymph node metastasis, have important significance on the treatment and prognosis of breast cancer. If breast cancer recurrence, the main causes of death were axillary lymph node metastases [14]. The scope and number of the lymph node dissection can effect the treatment and prognosis of patients [15]. Through initial analysis of breast cancer pathological type, we believe that breast cancer with axillary lymph node metastasis is closely related to the tumor size, and the number of cell mitoses is closely related to axillary lymph node metastasis too. Therefore, more attention should be paid to comedo necrosis during clinical process.

Acknowledgment

This study was supported by Shanghai Pudong Science and Technology Commission, China. (Grant No.: PKJ2014-Y23).

References

  1. Rosa Mendoza ES, Moreno E, Caguioa PB (2013) Predictors of early distant metastasis in women with breast cancer. J Cancer Res Clin Oncol 139: 645-652. [Crossref]
  2. Kong Y, Wang J, Liu W, Chen Q, Yang J, et al. (2013) Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients. PLoS One 8: e57092.
  3. Fisher ER, Land SR, Saad RS, Fisher B, Wickerham DL, et al. (2007) Pathologic Variables Predictive of Breast Events in Patients With Ductal Carcinoma In Situ. Am J Clin Pathol 128: 86-91. [Crossref]
  4. Lee JH, Suh YJ, Shim BY, Kim SH (2011) The incidence and predictor of lymph node metastasis for patients with T1mi breast cancer who underwent axillary dissection and breast irradiation: an institutional analysis. Jpn J Clin Oncol 41:1162-1167. [Crossref]
  5. Stackievicz R, Paran H, Bernheim J, Shapira M, Weisenberg N, et al. (2010) Prognostic significance of HER-2/neu expression in patients with ductal carcinoma in situ. Isr Med Assoc J 12: 290-295. [Crossref]
  6. Shekhar MP, Tait L, Pauley RJ, Wu GS, Santner SJ, et al. (2008) Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biol Ther 7: 1774-1782. [Crossref]
  7. Lehr HA, Rochat C, Schaper C, Nobile A, Shanouda S, et al. (2013) Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas. Mod Pathol 26: 336-342. [Crossref]
  8. Sarode VR, Han JS, Morris DH, Peng Y, Rao R, et al. (2011) A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy. International Journal of Breast Cancer, 2011:1-7.
  9. Bolton KL, Garcia-Closas M, Pfeiffer RM, Duggan MA, Howat WJ, et al. (2010) Assessment of Automated Image Analysis of Breast Cancer. Tissue Microarrays for Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev 19: 992-999. [Crossref]
  10. Mohammed ZM, McMillan DC, Elsberger B, Going JJ, Orange C, et al. (2012) Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer. Br J Cancer 106: 383 – 388, 2012. [Crossref]
  11. Konsti J, Lundin M, Joensuu H, Lehtimäki T, Sihto H, et al. (2011) Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer. BMC Clin Pathol 11: 3-11. [Crossref]
  12. Fasanella S, Leonardi E, Cantaloni C, Eccher C, Bazzanella I, et al. (2011) Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn Pathol 6: S1- S7. [Crossref]
  13. Johnson RH, Chien FL, Bleyer A (2013) Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009. JAMA 309: 800-805. [Crossref]
  14. Fayanju OM, Nwaogu I, Jeffe DB, Margenthaler JA (2015) Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator. Mol Clin Oncol 3: 775-780.
  15. Baghestani AR, Shahmirzalou P, Zayeri F, Akbari ME, Hadizadeh M, et al. (2015) Prognostic Factors for Survival in Patients with Breast Cancer Referred to Omitted Cancer Research Center in Iran. Asian Pac J Cancer Prev 16: 5081-5084. [Crossref]

Editorial Information

Editor-in-Chief

Rawhi Omar
University of Louisville School of Medicine

Article Type

Research Article

Publication history

Received date: October 01, 2017
Accepted date: October 17, 2017
Published date: October 21, 2017

Copyright

© 2017 Yueling Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Yueling Jin, Zhensheng Dai (2017) Clinical pathological analysis in 104 ductal breast cancer cases. Clin Diagn Pathol 1: DOI: 10.15761/CDP.1000118

Corresponding author

Zhensheng Dai

Department of Hematology-Oncology, Shanghai Pudong Hospital Affiliated to Fudan University, Shanghai, 201399, China

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Figure 1.

Figure 2. Age of breast cancer patients. 1: ≦30y,2; 31-40y; 3:41-50y, 4: 51-60y, 5; 61-70y, 6: ≧71y.

Table 1. The relationship between tumor size and lymph node metastasis.

Tumor size

number of patient (cases)

lymph node (+) (cases/percentage)

lymph node (-) (cases/percentage)

T1

35

9(25.7%)

24(74.3%)

T2

56

29(51.8%)

28(48.2%)

T3

13

12(92.3%)

2(7.7%)

lymph node positive rate of group T2 compared with group T1, P = 0.0418, P<0.05;T3compared with T2, P = 0.0184, P<0.05;T3 compared with T1, P = 0.0003, P<0.05.

Table 2. The relationship between comedo necrosis, lymph node metastasis and stage of breast cancer.

grade

n

comedo necrosis/ lymph node (+)

comedo necrosis/ lymph node (-)

15

2(13.3%)

3(20.0%)

29

10(34.5%)

7(24.1%)

59

27(45.8%)

11(18.6%)

uncertain

1

 

 

n: number of cases. Group comedo necrosis/ lymph node (+) compared with group comedo necrosis/ lymph node (+), P>0.05).

Table 3. The relationship between the number of cell mitoses and axillary lymph nodes metastasis.

number of cell mitoses

n

lymph node (+)

lymph node (-)

0-9 

54

19(35.2%)

35(64.8%)

≧10  

50

31(62.0%)

19(38.0%)

n: number of cases. The number of patients with axillary lymph node metastasis in group II more than that of group I, the difference was statistically significant(P=0.0139;P<0.05).